Aeterna Zentaris Abstract Accepted for Presentation at 13th

– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan...

Related Keywords

Greece , Athens , Attikír , Canada , Toronto , Ontario , Ukraine , Canadian , Lou Gehrig , Jenene Thomas , Klaus Paulini , Valentin Bruttel , School Of Medicine , Department Of Obstetrics , Linkedin , Aeterna Zentaris , Company On Twitter , European Commission , Megaron Athens International Conference Centre , Nasdaq , University Of Wuerzburg The , Aeterna Zentaris Inc , Toronto Stock Exchange , Facebook , International Congress On Autoimmunity , Novo Nordisk , Autoimmunity Modifying Biologicals , International Congress , Senior Researcher , Parallel Session , Nervous System , Chief Executive Officer , Neuromyelitis Optica Spectrum Disorder , Litigation Reform Act , Novo Amended License Agreement , Annual Report , Nasdaq Aezs , Nmosd , Orphan Indication , Medical Need , Sx Aezs , Iopharmaceutical Company ,